関連する実験動画

Updated: Feb 17, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

11.1K

米国国立コホートにおける肝硬変患者のアルファ-1アンチトリプシン欠乏症

Binu V John1,2, Dustin Bastaich1,3, Andres Samos1,4

  • 1Division of Gastroenterology and Hepatology, Miami VA Medical System.

Clinical and translational gastroenterology
|February 16, 2026
PubMed
まとめ

アルファ-1アンチトリプシン欠乏症 (AATD) 検査は,肝硬変患者の低値です. 高リスクの個人は検査を受ける可能性が低いため,病因にかかわらず,肝硬変のAATDスクリーニングを普遍的に行う必要があります.

キーワード:
アルファ1-アンチトリプシン欠乏症アルファ-1アンチトリプシン欠乏症に関連する肝疾患慢性肝疾患 慢性肝疾患 慢性肝疾患は,慢性肝疾患で,慢性肝疾患は慢性肝疾患で,慢性肝疾患は慢性肝疾患で,慢性肝疾患は慢性肝疾患で,慢性肝疾患は慢性肝疾患です.肝硬変 (Cirrhosis) が発症しています.遺伝子型 ゲノタイプフェノタイプ フェノタイプ フェノタイプ

さらに関連する動画

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

12.4K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.2K

関連する概念動画

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
212
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
257
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K